Skip to main content

Table 2 Treatment characteristics

From: Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy

Fraction/Dose

 

 48 Gy/4f

14 (15%)

 50 Gy/4f

5 (5%)

 50 Gy/5f

54 (57%)

 54 Gy/3f

3 (3%)

 60 Gy/5f

19 (20%)

BED-Gy

 

 Median

100

 Range

100–151.2

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us